================================================================================
R2AQ1 - RESPOSTA AOS REVISORES
================================================================================

COMENTÁRIO DO REVISOR:
"Does the paper contribute to the body of knowledge? The manuscript contributes 
a valuable market-mapping dataset of 96 wireless EEG and fNIRS devices (125 
including variants), compiled via a PRISMA-ScR protocol and OSF registration. 
This large-scale technical catalog is useful for researchers making 
device-selection decisions. However, its scientific advancement is limited, 
because the paper is primarily descriptive and does not provide critical 
synthesis, benchmarking, or analytical interpretation of device performance, 
clinical applicability, or research validation."

================================================================================
RESPONSE TO REVIEWERS (INGLÊS):
================================================================================

We thank the reviewer for acknowledging the value of the market-mapping 
dataset compiled in this review. We respectfully address the concern 
regarding the descriptive nature of the work and clarify why this 
contribution remains scientifically valid and necessary.

**Affirmative response:** Yes, this paper contributes to the body of 
knowledge. The systematic catalog of 96 wireless EEG and fNIRS devices 
(125 including variants), compiled following PRISMA-ScR guidelines and 
registered in the OSF, represents the most comprehensive device-level 
mapping of portable brain monitoring technologies currently available 
in the peer-reviewed literature.

**Acknowledgment of descriptive character:** We acknowledge that this 
scoping review is primarily descriptive rather than evaluative. The 
work does not include experimental benchmarking, signal quality 
validation, or direct clinical assessment of the identified devices. 
This scope is intentional and appropriate for a scoping review, which 
aims to map the extent and nature of available evidence rather than 
synthesize effectiveness or compare interventions.

**Justification of scientific validity:** Despite its descriptive 
nature, this work addresses a genuine gap in the literature. Prior to 
this review, no single resource provided:

1. **Comprehensive coverage:** A unified catalog spanning 96 devices 
   from multiple manufacturers, countries, and technology categories 
   (EEG and fNIRS), systematically organized for comparison.

2. **Standardized technical parameters:** Consistent reporting of 
   specifications (channels, sampling rate, electrode type, wireless 
   protocol, software, price) enabling direct cross-device comparison.

3. **Research adoption indicators:** Bibliometric quantification of 
   device usage in the scientific literature, providing evidence-based 
   guidance for researchers unfamiliar with the market landscape.

4. **Decision-support framework:** Practical organization of technical 
   and operational criteria to support informed device selection aligned 
   with specific research or clinical requirements.

The absence of experimental benchmarking reflects the scope of a scoping 
review rather than a limitation of scientific rigor. Benchmarking studies 
require controlled laboratory conditions, standardized protocols, and 
direct access to multiple devices—resources that typically require 
manufacturer collaboration or dedicated grant funding. The present work 
provides the foundational mapping upon which future benchmarking studies 
can be designed, identifying the universe of devices and their reported 
specifications as a necessary first step.

Furthermore, descriptive synthesis has established value in rapidly 
evolving technological fields. The neurotechnology market changes 
frequently, with new devices, firmware updates, and discontinued 
products appearing annually. A comprehensive, current mapping provides 
researchers with a snapshot of the commercial landscape that would 
otherwise require extensive individual investigation.

In summary, while we acknowledge the descriptive character of this 
review, we maintain that the systematic, large-scale mapping of brain 
monitoring devices represents a valid and necessary scientific 
contribution that fills a recognized gap and supports evidence-based 
decision-making in the neuroscience and neurorehabilitation communities.

================================================================================
ARGUMENTOS-CHAVE PARA A RESPOSTA:
================================================================================

1. SCOPING REVIEWS SÃO DESCRITIVOS POR NATUREZA
   - O objetivo é mapear, não sintetizar eficácia
   - Segue guidelines PRISMA-ScR específicas para esse tipo de revisão
   - Registrado prospectivamente no OSF (rigor metodológico)

2. O MAPEAMENTO PREENCHE UMA LACUNA REAL
   - Nenhum recurso único compilava 96 dispositivos antes
   - Especificações estavam dispersas em sites, manuais, literatura
   - Pesquisadores gastavam tempo significativo buscando informações

3. BENCHMARKING REQUER OUTRO TIPO DE ESTUDO
   - Exige acesso físico aos dispositivos
   - Requer laboratório e protocolos padronizados
   - O mapeamento é pré-requisito para benchmarking futuro

4. VALOR PRÁTICO É CONTRIBUIÇÃO CIENTÍFICA
   - Suporta tomada de decisão baseada em evidências
   - Economiza tempo de pesquisadores
   - Identifica tendências e padrões no mercado

================================================================================
FRASE DE SÍNTESE (para usar no manuscrito se necessário):
================================================================================

"Although this scoping review is primarily descriptive, it provides a 
foundational resource that was previously unavailable in the literature. 
The systematic catalog of devices, specifications, and adoption patterns 
enables evidence-based device selection and serves as a prerequisite for 
future benchmarking and validation studies."

================================================================================
CHECKLIST DE IMPLEMENTAÇÃO:
================================================================================

[ ] 1. Esta resposta é principalmente para o Response to Reviewers
[ ] 2. Verificar se o manuscrito já inclui justificativa similar
[ ] 3. Se necessário, adicionar frase de síntese na Discussion
[ ] 4. Garantir consistência com R1AQ1 (contribuição original)

================================================================================
NOTAS:
================================================================================

- O revisor já reconhece o valor ("valuable market-mapping dataset")
- A crítica é sobre TIPO de contribuição, não sobre FALTA de contribuição
- A resposta deve ser respeitosa mas firme na defesa do escopo escolhido
- Scoping reviews são metodologia estabelecida (JBI, Arksey & O'Malley)
